An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
The mRNA-1273 vaccine induced anti-SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified. These findings support further develop...
Publications
View AllSafety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
In this small study involving older adults, adverse events associated with the mRNA-1273 vaccine were mainly mild or moderate. The 100-μg dose induced higher binding- and neutra...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- US
- Publications
- 3
- Citations
- 6,214
External Links
Identifiers
- ROR
- https://ror.org/050fhx250